Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney | 7 | 2014 | 155 | 1.670 |
Why?
|
| Kidney Diseases | 5 | 2014 | 98 | 1.460 |
Why?
|
| Renal Dialysis | 4 | 2016 | 115 | 1.450 |
Why?
|
| Biopsy, Needle | 5 | 2014 | 96 | 1.220 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2016 | 23 | 0.970 |
Why?
|
| Kidney Failure, Chronic | 3 | 2016 | 148 | 0.800 |
Why?
|
| Nephrosis, Lipoid | 1 | 2019 | 11 | 0.640 |
Why?
|
| Thrombosis | 2 | 2016 | 48 | 0.570 |
Why?
|
| Polyuria | 1 | 2017 | 2 | 0.560 |
Why?
|
| Antidiuretic Agents | 1 | 2017 | 2 | 0.560 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2017 | 5 | 0.560 |
Why?
|
| Lupus Nephritis | 2 | 2015 | 29 | 0.560 |
Why?
|
| Hyponatremia | 1 | 2017 | 8 | 0.550 |
Why?
|
| Nephrology | 1 | 2016 | 8 | 0.520 |
Why?
|
| Hematuria | 2 | 2014 | 16 | 0.510 |
Why?
|
| Urologic Surgical Procedures | 1 | 2012 | 10 | 0.400 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 24 | 0.390 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 46 | 0.380 |
Why?
|
| Porphyria Cutanea Tarda | 1 | 2010 | 3 | 0.340 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2010 | 11 | 0.330 |
Why?
|
| Humans | 17 | 2020 | 25692 | 0.320 |
Why?
|
| Constriction, Pathologic | 3 | 2016 | 31 | 0.310 |
Why?
|
| Male | 10 | 2020 | 13917 | 0.270 |
Why?
|
| Acid-Base Imbalance | 1 | 2004 | 3 | 0.230 |
Why?
|
| Middle Aged | 7 | 2020 | 8403 | 0.210 |
Why?
|
| Prospective Studies | 4 | 2014 | 1633 | 0.200 |
Why?
|
| Hypercalcemia | 1 | 2020 | 11 | 0.180 |
Why?
|
| Calcitonin | 1 | 2020 | 14 | 0.180 |
Why?
|
| Diphosphonates | 1 | 2020 | 15 | 0.180 |
Why?
|
| Prednisone | 1 | 2019 | 58 | 0.160 |
Why?
|
| Aged | 5 | 2020 | 8501 | 0.160 |
Why?
|
| Nephrotic Syndrome | 1 | 2019 | 24 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 75 | 0.150 |
Why?
|
| Recurrence | 1 | 2019 | 275 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 124 | 0.150 |
Why?
|
| Neoplasms | 1 | 2020 | 224 | 0.140 |
Why?
|
| Female | 7 | 2020 | 14273 | 0.140 |
Why?
|
| Self Medication | 1 | 2017 | 3 | 0.140 |
Why?
|
| Osmolar Concentration | 1 | 2017 | 20 | 0.140 |
Why?
|
| Urinalysis | 1 | 2017 | 9 | 0.140 |
Why?
|
| Hypothalamus | 1 | 2017 | 13 | 0.140 |
Why?
|
| Prognosis | 1 | 2019 | 739 | 0.130 |
Why?
|
| Risk Factors | 3 | 2012 | 2224 | 0.130 |
Why?
|
| Adult | 5 | 2014 | 7336 | 0.130 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2015 | 15 | 0.120 |
Why?
|
| Automation | 1 | 2014 | 8 | 0.120 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2015 | 30 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 47 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 120 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 37 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 311 | 0.120 |
Why?
|
| Adolescent | 3 | 2014 | 2076 | 0.110 |
Why?
|
| Young Adult | 3 | 2014 | 1855 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 68 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 913 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 299 | 0.100 |
Why?
|
| Logistic Models | 1 | 2014 | 366 | 0.100 |
Why?
|
| Biomarkers | 1 | 2015 | 554 | 0.100 |
Why?
|
| Age Factors | 2 | 2012 | 716 | 0.100 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 19 | 0.090 |
Why?
|
| Pregnancy | 1 | 2012 | 291 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2011 | 75 | 0.090 |
Why?
|
| Sex Factors | 1 | 2012 | 427 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 13 | 0.080 |
Why?
|
| Glucose | 1 | 2009 | 50 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 731 | 0.080 |
Why?
|
| Biopsy | 2 | 2009 | 199 | 0.080 |
Why?
|
| United States | 2 | 2011 | 1943 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4459 | 0.060 |
Why?
|
| Confusion | 1 | 2004 | 4 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 6 | 0.060 |
Why?
|
| Hypokalemia | 1 | 2004 | 4 | 0.060 |
Why?
|
| Psychomotor Agitation | 1 | 2004 | 13 | 0.060 |
Why?
|
| Feeding and Eating Disorders | 1 | 2004 | 12 | 0.060 |
Why?
|
| Potassium | 1 | 2004 | 64 | 0.060 |
Why?
|
| Time Factors | 1 | 2004 | 1336 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3220 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2004 | 3231 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 139 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 235 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 646 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1689 | 0.020 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2009 | 9 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 92 | 0.020 |
Why?
|
| Renal Replacement Therapy | 1 | 2005 | 20 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 60 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 435 | 0.010 |
Why?
|